Non-surgical treatment of uterine fibroids(Uterine Fibroid Embolization and MWA ablation of Uterine Fibroids))(click for arabic)

What is uterine fibroid?

Uterine fibroids, also known as leiomyomas, are noncancerous growths that develop in the uterus. Fibroids can vary in size and number and are usually benign, meaning they are not cancerous.

Fibroids are very common, and many women may have them without even knowing it. In fact, it is estimated that up to 80% of women will develop fibroids by the age of 50. Fibroids can be found anywhere in the uterus, and they can grow in different directions, including inward, outward, and along the uterine wall.

Fibroids can cause a variety of symptoms, such as heavy menstrual bleeding, prolonged periods, pelvic pain or pressure, frequent urination, constipation, and infertility. However, many women with fibroids may not experience any symptoms at all.

The exact cause of fibroids is not known, but they are believed to be influenced by hormones, particularly estrogen and progesterone. Other factors that may increase the risk of developing fibroids include age, family history, obesity, and certain medical conditions such as endometriosis.

What are the treatment options for fibroids?

There are several treatment options available for uterine fibroids, including:

Watchful waiting: If fibroids are not causing any significant symptoms, a healthcare provider may recommend watchful waiting, which involves monitoring the fibroids over time to ensure they are not growing or causing any health issues.

Medications: Hormonal medications, such as birth control pills or hormone replacement therapy, may help reduce the size of fibroids or alleviate symptoms, such as heavy bleeding or cramping. Other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or iron supplements, may also be used to manage symptoms.

Myomectomy: Myomectomy is a surgical procedure in which the fibroids are surgically removed from the uterus. This procedure may be recommended for women who wish to preserve their fertility or who have large or symptomatic fibroids that cannot be treated with other methods.

Hysterectomy: Hysterectomy is a surgical procedure in which the entire uterus is removed. This procedure may be recommended for women who have severe symptoms or who are not planning to have children in the future.

Uterine fibroid embolization (UFE): UFE is a minimally invasive procedure in which small particles are injected into the uterine arteries to block blood flow to the fibroids, causing them to shrink and die off over time. This procedure is typically recommended for women who have large or symptomatic fibroids but wish to preserve their fertility.

Magnetic resonance-guided focused ultrasound surgery (MRgFUS): MRgFUS is a non-invasive procedure that uses high-frequency ultrasound waves to destroy the fibroids without making any incisions. This procedure is typically recommended for women who have small or medium-sized fibroids that are causing significant symptoms.

The choice of treatment will depend on several factors, including the size and location of the fibroids, the severity of symptoms, the woman's age and future fertility goals, and her overall health status. It is important for women to discuss their treatment options with their healthcare provider to determine the most appropriate course of action for their individual needs.

What are benefits of UFE?

Uterine fibroid embolization (UFE) has several benefits for women with symptomatic fibroids, including:

Minimally invasive: UFE is a minimally invasive procedure that does not require any surgical incisions. Instead, the procedure is performed through a small puncture in the groin or wrist, which significantly reduces the risk of complications and shortens recovery time.

High success rates: UFE has been shown to be highly effective in treating fibroids, with success rates ranging from 85% to 95% in reducing or eliminating symptoms.

Preserves fertility: Unlike hysterectomy, UFE does not involve removing the uterus, which means that women who wish to preserve their fertility can still conceive and carry a pregnancy to term after the procedure.

Rapid symptom relief: Most women experience rapid relief of symptoms after UFE, with improvements in heavy bleeding, pelvic pain, and other symptoms occurring within a few weeks to a few months after the procedure.

Low complication rates: UFE has a low rate of complications, with less than 5% of women experiencing significant complications, such as infection, bleeding, or injury to nearby organs.

Outpatient procedure: UFE is typically performed as an outpatient procedure, which means that women can go home the same day as the procedure and return to their normal activities within a few days to a week.

Overall, UFE is a safe and effective treatment option for women with symptomatic fibroids, offering significant benefits over traditional surgical treatments, such as hysterectomy or myomectomy. However, it is important for women to discuss their treatment options with their healthcare provider to determine the most appropriate course of action for their individual needs.

What is Uterine Fibroid Embolization?

Uterine fibroid embolization (UFE) is a minimally invasive treatment option for uterine fibroids. Fibroids are noncancerous tumors that grow in the uterus and can cause a variety of symptoms, such as heavy menstrual bleeding, pelvic pain, and infertility. UFE involves blocking the blood supply to the fibroids, causing them to shrink and eventually die off.

The procedure is performed by an interventional radiologist, a specialist trained in using imaging techniques to guide minimally invasive procedures. The patient is usually given a mild sedative and local anesthesia to help with discomfort during the procedure.

How is it done?

To begin the procedure, the interventional radiologist makes a small incision in the groin area and inserts a catheter into an artery. Using X-ray guidance, the catheter is guided through the blood vessels and into the arteries that supply blood to the fibroids. Small particles are then injected through the catheter, blocking the blood flow to the fibroids and causing them to shrink.

UFE has been shown to be an effective treatment option for uterine fibroids, with high success rates and low rates of complications.

How long does the UFE procedure take?

The length of time it takes to perform a uterine fibroid embolization (UFE) procedure can vary depending on the individual case and the size and number of fibroids being treated. However, in general, the procedure typically takes between 30 minutes to an hour to complete.

After the procedure, the patient is typically monitored for a few hours to ensure that there are no complications or adverse reactions. Most patients are able to go home on the same day as the procedure and can resume their normal activities within a few days to a week, depending on their individual recovery progress.

How effective is UFE in treating fibroids?

Uterine fibroid embolization (UFE) is considered to be a highly effective treatment option for uterine fibroids, with success rates ranging from 85% to 95%. The procedure works by blocking the blood flow to the fibroids, causing them to shrink and eventually die off.

Studies have shown that UFE can lead to significant improvements in symptoms such as heavy menstrual bleeding, pelvic pain, and urinary frequency or urgency. In fact, many women report experiencing significant symptom relief within a few weeks after the procedure, with continued improvement over time.

One advantage of UFE over other treatment options for fibroids, such as surgery, is that it is a minimally invasive procedure that does not require general anesthesia or a lengthy hospital stay. Patients typically experience less pain and have a quicker recovery time compared to surgery.

Women who are interested in UFE should discuss their individual case with their healthcare provider to determine whether the procedure is appropriate for them, based on factors such as the size and location of their fibroids, their overall health, and their future fertility goals.

Indications for UFE

UFE is typically recommended for women who have symptomatic fibroids and wish to avoid surgery. Symptoms of fibroids can include heavy menstrual bleeding, pelvic pain, urinary frequency or urgency, and infertility. UFE is not recommended for women who are pregnant, have cancerous or pre-cancerous tumors, or have an active pelvic infection.

UFE can be a particularly good option for women who want to preserve their fertility. Unlike hysterectomy, which involves the removal of the entire uterus, UFE allows women to maintain their uterus and potentially have children in the future.

UFE can also be a good option for women who are not good candidates for surgery due to other health conditions, such as heart disease or obesity.

Procedure

The UFE procedure typically takes between one and two hours to complete, and patients can usually go home the same day. Before the procedure, the patient will meet with the interventional radiologist to discuss the procedure and any questions or concerns they may have.

During the procedure, the patient is given a mild sedative and local anesthesia to help with discomfort. The interventional radiologist makes a small incision in the groin area and inserts a catheter into an artery. Using X-ray guidance, the catheter is guided through the blood vessels and into the arteries that supply blood to the fibroids.

Once the catheter is in place, small particles are injected through the catheter, blocking the blood flow to the fibroids and causing them to shrink. The interventional radiologist may also use contrast dye to visualize the blood vessels and ensure that the particles are being delivered to the correct location.

After the particles have been injected, the catheter is removed and pressure is applied to the insertion site to prevent bleeding. The patient will then be monitored for several hours to ensure that there are no complications.

Outcomes

UFE has been shown to be an effective treatment option for uterine fibroids, with high success rates and low rates of complications. The majority of women who undergo UFE experience significant improvement in their symptoms, including a reduction in menstrual bleeding, pelvic pain, and urinary symptoms.

One study found that 85% of women who underwent UFE experienced improvement in their symptoms, with 50% experiencing complete resolution of their symptoms. Another study found that 90% of women who underwent UFE were satisfied with the results of the procedure.

UFE has also been shown to have a low rate of complications. The most common complication is pain and discomfort after the procedure, which can usually be managed with over-the-counter pain medication. Other potential complications include infection, damage to surrounding organs, and allergic reaction to the contrast dye.

In rare cases, UFE can lead to a condition called uterine necrosis, which is the death of uterine tissue. This can occur if the blood supply to the uterus is severely compromised during the procedure. However, the risk of uterine necrosis is very low, occurring in less than 1% of cases.

One potential downside of UFE is that it may not be as effective as surgery for larger fibroids. While UFE can be effective for fibroids up to about 10 cm in size, larger fibroids may not respond as well to the procedure.

Overall, UFE is a safe and effective treatment option for uterine fibroids, with high success rates and low rates of complications.

Will I experience pain during or after the procedure?

Most women who undergo uterine fibroid embolization (UFE) do experience some discomfort during and after the procedure. However, the level of pain can vary depending on the individual and the specific details of their case.

During the procedure, patients are typically given a mild sedative to help them relax, but they remain awake and alert throughout the procedure. Some women may experience cramping, pressure, or a feeling of warmth or burning as the particles are injected into the uterine artery.

After the procedure, women may experience cramping, pelvic pain, or discomfort for several days to a week. Pain medications, such as ibuprofen or acetaminophen, are usually prescribed to help manage any discomfort.

It is also common for women to experience vaginal discharge or spotting after UFE. This is normal and usually resolves within a few days to a week.

If you experience severe or persistent pain, fever, heavy bleeding, or any other concerning symptoms after UFE, it is important to contact your healthcare provider right away. They can help determine whether further evaluation or treatment is needed.

What are some possible risks and complications of UFE

Pain and discomfort: After the procedure, patients may experience cramping, pain, or discomfort in the pelvic region. This can usually be managed with over-the-counter pain medication.

Infection: Although rare, there is a risk of infection with any medical procedure. Patients will typically receive antibiotics before the procedure to reduce this risk.

Allergic reaction: There is a small risk of an allergic reaction to the contrast dye used during the procedure. Patients who are allergic to iodine or contrast dye should inform their healthcare provider before undergoing UFE.

Damage to surrounding organs: There is a small risk that the embolization material used to block the blood supply to the fibroids could migrate to other areas of the body, potentially causing damage to surrounding organs. However, this is a rare complication.

Early menopause: In rare cases, UFE can cause a decrease in blood supply to the ovaries, which can lead to early menopause. This is more likely to occur in women who are already close to menopause.

Uterine necrosis: In rare cases, UFE can lead to uterine necrosis, which is the death of uterine tissue. This can occur if the blood supply to the uterus is severely compromised during the procedure. However, the risk of uterine necrosis is very low, occurring in less than 1% of cases.

It is important to note that the risks and complications of UFE are generally lower than those associated with surgery. However, it is still important for women considering UFE to discuss these risks with their healthcare provider and make an informed decision about whether UFE is the best treatment option for them.

Could women have a child after undergoing UFE?

Yes, it is generally possible for women to have a child after undergoing uterine fibroid embolization (UFE). Unlike a hysterectomy, which involves the removal of the uterus and makes future pregnancy impossible, UFE preserves the uterus and its ability to support a pregnancy. There are many women that had children after UFE procedure in our own experience.

It is worth noting that the impact of UFE on fertility may vary depending on a number of factors, including the size and location of the fibroids, the woman's age, and her overall reproductive health. For women who wish to become pregnant after UFE, it is important to discuss their options with their healthcare provider and undergo regular monitoring to assess their fertility status.

In some cases, fertility treatments such as in vitro fertilization (IVF) may be recommended to help improve the chances of pregnancy. However, for women who wish to preserve their fertility, UFE may still be a viable option compared to more invasive procedures such as hysterectomy.

Fibroids can alter the shape of the uterus, block the fallopian tubes, or cause other issues that may make it more difficult to conceive or carry a pregnancy to term. Women who experience fertility issues related to fibroids should work closely with their healthcare provider to identify the underlying cause of their fertility problems and develop a treatment plan that is appropriate for their individual needs.

Does a fibroid return to cancer after UFE ? What happens if i undergo uterine fibroid embolization for fibroids but it was a cancer? What is the ratio of a cancer that coud be misdiagnosed as a fibroid?

Uterine fibroids do not typically turn into cancer. While it is true that uterine fibroids are composed of abnormal growths of cells, these cells are not cancerous and do not have the potential to turn into cancer.

It is important for women who have undergone UFE to undergo regular monitoring to detect any signs of uterine cancer or other complications. This may involve regular pelvic exams, ultrasounds, or other imaging tests. Women who experience any unusual symptoms, such as abnormal vaginal bleeding or pelvic pain, should also contact their healthcare provider right away for further evaluation.

If a cancer is discovered during or after uterine fibroid embolization (UFE), the treatment plan will depend on the type and stage of the cancer.

If the cancer is discovered during the UFE procedure, the interventional radiologist may stop the procedure and refer the patient to a gynecologic oncologist for further evaluation and treatment. This may involve additional imaging tests, such as magnetic resonance imaging (MRI) or computed tomography (CT) scans, as well as a biopsy to determine the type of cancer.

If the cancer is discovered after the UFE procedure, the patient will likely be referred to a gynecologic oncologist for further evaluation and treatment. The oncologist may recommend additional imaging tests or a biopsy to determine the extent of the cancer and whether it has spread to other parts of the body.

Treatment options for uterine cancer may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The specific treatment plan will depend on the type and stage of the cancer, as well as the patient's overall health and preferences.

It is important to note that while UFE itself does not cause cancer, it is possible for cancer to be present in the uterus at the time of the procedure. This is why it is important for women to undergo regular pelvic exams and other screening tests to detect any signs of cancer or other abnormalities in the uterus. Women who have a history of uterine cancer or who are at increased risk for the disease may also be advised to undergo additional screening tests or to consider alternative treatment options for uterine fibroids.

It is difficult to provide a precise ratio of the number of uterine cancers that are misdiagnosed as fibroids, as this can vary depending on a number of factors such as the size and location of the growth, the skill and experience of the healthcare provider, and the specific diagnostic tools used.

However, it is important to note that while uterine fibroids are typically benign growths that are not associated with an increased risk of cancer, it is still possible for cancerous growths to occur in the uterus. In fact, some studies suggest that as many as 1-2% of uterine fibroids may actually be cancerous.

It is therefore important for healthcare providers to carefully evaluate any growths in the uterus and to use appropriate diagnostic tools, such as imaging tests or biopsies, to determine whether the growth is a fibroid or a cancer. Women who experience symptoms such as abnormal vaginal bleeding, pelvic pain, or other unusual symptoms should seek prompt medical attention and may need to undergo further evaluation to determine the cause of their symptoms.

Overall, while UFE is generally considered a safe and effective treatment option for uterine fibroids, it is important for women to weigh the potential risks and benefits of the procedure and to discuss their options with their healthcare provider.

Conclusion

Uterine fibroid embolization is a minimally invasive procedure that can be an effective alternative to surgery for women with symptomatic fibroids. The procedure involves blocking the blood supply to the fibroids, causing them to shrink and eventually die off.

UFE has been shown to have high success rates and low rates of complications, making it a safe and effective treatment option for women who wish to avoid surgery or who are not good candidates for surgery. The procedure is typically performed on an outpatient basis and patients can usually go home the same day.

While UFE may not be as effective as surgery for larger fibroids, it can be an excellent option for women who want to preserve their fertility or who are not good candidates for surgery due to other health conditions. If you are experiencing symptoms of uterine fibroids, talk to your healthcare provider about whether UFE might be a good option for you.

 

Non-Surgical Treatment of Uterine Fibroids with Microwave Ablation (MWA)

A Modern, Uterus-Preserving, Minimally Invasive Solution

Uterine fibroids (leiomyomas) are the most common benign tumors of the female reproductive system, affecting up to 60–70% of women during their lifetime. Although many fibroids remain asymptomatic, a significant proportion cause symptoms that negatively affect quality of life, including heavy menstrual bleeding, pelvic pain, pressure symptoms, anemia, and fertility-related concerns.

Microwave Ablation (MWA) is a modern, image-guided, minimally invasive treatment option for selected uterine fibroids. It offers effective symptom relief while preserving the uterus, avoiding major surgery, and enabling rapid recovery.


What Are Uterine Fibroids?

Uterine fibroids are non-cancerous growths originating from the smooth muscle layer of the uterus. They vary in size, number, and location, and are commonly classified as:

  • Intramural fibroids (within the uterine wall)
  • Subserosal fibroids (growing outward from the uterus)
  • Submucosal fibroids (projecting into the uterine cavity)

Symptoms depend on fibroid size and location and may include:

  • Heavy or prolonged menstrual bleeding
  • Pelvic pain or pressure
  • Frequent urination or constipation
  • Pain during intercourse
  • Anemia-related fatigue
  • Fertility or pregnancy-related issues

What Is Microwave Ablation (MWA) for Uterine Fibroids?

Microwave ablation is a thermal ablation technique that uses high-frequency electromagnetic waves to generate heat within the fibroid tissue. This controlled heat causes coagulative necrosis, leading to gradual shrinkage of the fibroid and improvement of symptoms over time.

The procedure is performed under real-time imaging guidance (ultrasound and/or CT), ensuring precise targeting of the fibroid while protecting surrounding healthy uterine tissue.

MWA does not remove the fibroid surgically; instead, it destroys fibroid tissue from within, allowing the body to naturally resorb the treated area over months.


How Is the Procedure Performed?

  1. Pre-procedural evaluation
    • Detailed gynecologic assessment
    • Pelvic MRI or ultrasound to determine fibroid size, location, and suitability
    • Blood tests and clinical evaluation
  2. During the procedure
  3. Performed under conscious sedation or general anesthesia
  4. A thin microwave antenna is inserted percutaneously or transvaginally into the fibroid under imaging guidance
  5. Microwave energy is delivered for a controlled duration
  6. Surrounding organs are continuously monitored
  7. Short hospital stay or same-day discharge
  8. Rapid return to daily activities
  9. Gradual fibroid shrinkage over weeks to months
  10. After the procedure

Who Is a Suitable Candidate for Uterine Fibroid MWA?

MWA is most suitable for:

  • Women with symptomatic fibroids who wish to avoid surgery
  • Patients seeking uterus-preserving treatments
  • Women not ideal candidates for myomectomy or hysterectomy
  • Patients with intramural or subserosal fibroids of appropriate size
  • Selected patients with fertility concerns (after individualized evaluation)

Each patient must be assessed individually by a multidisciplinary team to determine the most appropriate treatment option.


Advantages of Microwave Ablation for Fibroids

  • Minimally invasive – no large incisions
  • Uterus-sparing treatment
  • Short recovery time
  • Lower complication rates compared to surgery
  • Reduced blood loss
  • Preservation of normal uterine anatomy
  • Can be combined with other interventional treatments when necessary

MWA vs. Other Treatment Options

Treatment

Invasiveness

Uterus Preservation

Recovery

Hysterectomy

High

❌ No

Long

Myomectomy

Moderate–High

✅ Yes

Moderate

Uterine Fibroid Embolization (UFE)

Minimally invasive

✅ Yes

Short

Microwave Ablation (MWA)

Minimally invasive

✅ Yes

Very short

MWA offers a highly targeted approach with minimal systemic impact.


Scientific Evidence and Clinical Outcomes

Clinical studies have demonstrated that microwave ablation:

  • Achieves significant fibroid volume reduction
  • Provides sustained symptom relief
  • Improves quality of life scores
  • Has a favorable safety profile when performed by experienced specialists

Ongoing research continues to refine patient selection and long-term outcomes, particularly in combination with other minimally invasive therapies.


Safety and Ethical Considerations

  • Performed according to international interventional radiology standards
  • Evidence-based patient selection
  • Informed consent with detailed explanation of alternatives
  • Transparent discussion of benefits, risks, and expectations
  • Not a replacement for surgery in all cases; individualized decision-making is essential

Recovery and Follow-Up

  • Mild pelvic discomfort for a few days is common
  • Most patients return to normal activities within 24–72 hours
  • Follow-up imaging (MRI or ultrasound) is performed to assess fibroid shrinkage
  • Symptom improvement continues progressively over months

Why Choose an Interventional Radiology–Based Approach?

Interventional radiology offers image-guided, precision treatments that minimize trauma while maximizing outcomes. Procedures such as uterine fibroid MWA require:

  • Advanced imaging expertise
  • Detailed knowledge of pelvic vascular and uterine anatomy
  • High procedural experience

Outcomes are highly operator-dependent.


Conclusion

Microwave Ablation for uterine fibroids is a safe, effective, and uterus-preserving treatment option for selected patients seeking a non-surgical solution. When performed in experienced centers, it offers meaningful symptom relief, rapid recovery, and high patient satisfaction.

A personalized evaluation is essential to determine whether MWA is the most appropriate treatment for your condition.

Why Choose Our Center for Interventional Radiology?

Choosing the right center for an interventional radiology procedure is one of the most important decisions you will make for your health.
Beyond the technique itself, who performs the procedure, where it is performed, and how it is planned directly influence safety, success, and long-term outcomes.

At our center, we are committed to academic excellence, ethical medical practice, and truly patient-centered care.


1. Treatment Performed by an Internationally Recognized Academic Expert

All procedures are personally performed by Prof. Dr. Fahrettin Küçükay,
an internationally recognized Professor of Interventional Radiology with extensive experience in advanced and complex minimally invasive treatments.

His background includes:

  • Many years of high-volume clinical experience
  • International scientific publications and academic contributions
  • Guideline-based, evidence-driven medical practice
  • Referral experience for complex and high-risk cases

In interventional radiology, outcomes are highly operator-dependent.
The same procedure can yield very different results depending on the physician’s expertise, judgment, and experience.


2. A Trusted Academic Referral Center

All treatments are performed at Eskişehir Osmangazi University Faculty of Medicine,
a well-established university hospital and academic referral center.

This setting provides:

  • Multidisciplinary collaboration when required
  • Advanced imaging and patient monitoring facilities
  • Full compliance with international medical standards
  • An infrastructure designed for complex medical decision-making, not routine shortcuts

Academic centers differ fundamentally from small private clinics in terms of safety, oversight, and clinical depth.


3. Highest Standards in Medical Materials and Technology

We strictly use:

  • Original, brand-name medical devices
  • Single-use, disposable materials only
  • Products from internationally recognized manufacturers
  • Advanced angiography and imaging systems

In interventional radiology, material quality directly affects:

  • Procedural safety
  • Technical success
  • Complication risk
  • Long-term outcomes

We never compromise quality for cost reduction.


4. Personalized, Patient-Specific Treatment Planning

Every patient is evaluated individually.
There is no “one-size-fits-all” approach.

Treatment planning is based on:

  • Individual anatomy
  • Disease characteristics
  • Previous treatments
  • Overall health status

We clearly explain:

  • Who is an appropriate candidate
  • Who may not benefit from the procedure
  • Expected outcomes and realistic limitations

We believe that transparent and honest medicine builds long-term trust.


5. What Our Pricing Reflects

Our pricing represents a comprehensive medical service, not merely a technical procedure.

It includes:

  • Expert medical evaluation and decision-making
  • Treatment performed by a senior academic specialist
  • High-quality materials and advanced technology
  • Hospital care and post-procedure monitoring
  • Medical reports and documentation in English
  • Post-treatment follow-up and continued availability for questions

Our approach prioritizes safety, expertise, and ethical medical practice.


6. Understanding Treatment Costs and Comparisons

We recognize that patients may encounter different price offers across countries and centers.
However, in medicine—especially in technically demanding minimally invasive procedures—cost must always be evaluated together with experience, safety, and long-term results.

Lower prices may reflect differences in:

  • Physician experience
  • Hospital infrastructure
  • Quality of materials
  • Patient selection and follow-up standards

Our goal is not to be the cheapest option, but to be a reliable, evidence-based, and trusted choice.


7. Our Commitment to Patients

Responsible medicine does not promise guaranteed results.
Instead, we commit to:

  • Honest medical evaluation
  • Evidence-based treatment decisions
  • The highest safety standards
  • Respect for every patient as an individual

Many international patients choose our center because they value experience, transparency, and peace of mind.


8. Why Turkey and Why Eskişehir?

Why Turkey?

Turkey is a leading destination for international patients due to its:

  • Advanced medical infrastructure
  • Highly trained academic physicians
  • Evidence-based healthcare systems
  • European-level medical quality with excellent accessibility and value

Why Eskişehir?

Eskişehir offers a unique advantage for recovery:
safe, calm, and patient-friendly city.

Compared to crowded metropolitan areas, Eskişehir provides:

  • A peaceful, low-stress environment
  • Easy transportation and short travel distances
  • A clean, modern, and well-organized city structure
  • Rich cultural life without congestion or crowds

This combination allows patients to receive high-level academic medical care while recovering in a comfortable, human-scale, and welcoming environment.


Contact & Further Information

If you would like a personalized evaluation or wish to share medical reports or imaging studies, we encourage you to contact us.
Our team will guide you professionally, transparently, and respectfully.

Prof.Dr.Fahrettin Küçükay

email: fkucukay@hotmail.com
instagram: https://www.instagram.com/fahrettinkucukay/
facebook: https://www.facebook.com/ProfDrFKucukay
hospital contact: https://hastane.ogu.edu.tr/Sayfa/Index/14/contact
Adress: Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Hastanesi. Girişimsel Radyoloji bölümü. 1. kat. Büyükdere Mh. Osmangazi Üniversitesi Meşelik Kampüsü ESKİŞEHİR/TURKEY
assistance: Tülay Başal +90531 904 03 89
 

OTHER NONSURGICAL TREATMENT SOLUTIONS (Please click the link)